$BSX $COST $EXPE $MRVL $UTL
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is the list for Monday, 9 March, as follows:
Boston Scientific Corp. (NYSE:BSX) was maintained as Outperform but its target was cut to 46 from 51 at Credit Suisse.
Costco Wholesale Corp. (NASDAQ:COST)Raymond James reiterated its Outperform rating but raised its 315 prior target price up to 325. UBS reiterated its Buy rating and raised its target to 355 from 335.
Expedia Group Inc. (NASDAQ:EXPE) was started with a Buy rating and a 130 target price at Citigroup.
Marvell Technology Group Ltd. (NASDAQ:MRVL) rallied over 10% to $24.93 after strong earnings and guidance, despite some panic selling last week. Argus reiterated it as Buy with a 30 target price, and the firm talked up its focus on infrastructure as the right place to be at this time.
Unitil Corp. (NYSE:UTL) was raised to Buy from Neutral and the target price was maintained at 63 at Janney, with the firm noting that the call is after the sell-off created an attractive entry point.
Have a terrific week